NCT05840562 - Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy | Biotech Hunter

Enrollment

274

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG

Capsaicin

Application of capsaicin patches 179 mg

DRUG

Duloxetine

Administration of duloxetine

Trial Locations (11)

14076

RECRUITING

Centre François Baclesse, Caen

31059

RECRUITING

Institut Claudius Regaud -IUCT-O, Toulouse

33075

RECRUITING

CHU Bordeaux, Bordeaux

38043

RECRUITING

CHU Grenoble, Grenoble

44200

RECRUITING

"L'Hôpital Privé du Confluent ", Nantes

44805

RECRUITING

Institut de Cancérologie de l'Ouest, Saint-Herblain

49055

RECRUITING

Institut de Cancérologie de l'Ouest, Angers

67033

RECRUITING

Institut de Cancérologie Strasbourg Europe, Strasbourg

69373

RECRUITING

Centre Léon Bérard, Lyon

87039

RECRUITING

Polyclinique Chenieux, Limoges

06189

RECRUITING

Centre Antoine Lacassagne, Nice